The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis
The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis
复制标题
DOI：
10.1016/s0165-2427(01)00312-9
复制
发表时间：
2001-09-20
影响因子：
1.8
通讯作者：
Hillier, A
中科院分区：
文献类型：
--
作者：
DeBoer, DJ;Hillier, A
人和犬的特应性皮炎（AD）的临床体征是可变的，并且没有单一的物理或历史特征（如果存在）表明存在AD。AD的初步诊断在临床上是通过满足与该疾病密切相关的标准的组合来进行的。已经提出了几种方案，试图定义诊断犬AD的统一临床标准，但没有一个系统是完美的。一旦AD被认为是一种可能的诊断，其他重要的鉴别诊断必须有条不紊地排除考虑。作为最后一步，一旦临床医生确定AD是可能的，可以进行“过敏”测试，以提供额外的证据来“证实”诊断。重要的是要理解，过敏试验，无论以何种形式，都不适合在患者评估早期作为筛查试验使用。相反，它应该保留后，AD的坚定的临床诊断已经作出，实施过敏原避免计划或选择过敏原纳入免疫治疗制剂。(C)2001 Elsevier Science B.V.保留所有权利。
The clinical signs of atopic dermatitis (AD) in man and in dogs are variable, and there is no single physical or historical feature that, if present, indicates the presence of AD. The initial diagnosis of AD is made clinically with the fulfillment of a combination of criteria that are strongly associated with the disease. Several schemes have been proposed in an attempt to define uniform clinical criteria for diagnosing canine AD, but no system is perfect. Once AD is considered as a possible diagnosis, other important differential diagnoses must be methodically eliminated from consideration. As a final step, once the clinician is certain that AD is probable, "allergy" tests may be conducted to provide additional evidence to "substantiate" the diagnosis. It is important to understand that allergy testing, in whatever form, is not appropriately used early in the patient evaluation as a screening test. Rather, it should be reserved, after a firm clinical diagnosis of AD has been made, to implement allergen avoidance schemes or to select allergens to be incorporated in immunotherapy formulations. (C) 2001 Elsevier Science B.V. All rights reserved.